SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 06/09/2025 at 07:00, 9 months 15 days ago

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants

Healthcare Sanofi Vaccine RSV Beyfortus
BRIEF

published on 06/06/2025 at 20:27, 9 months 17 days ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
BRIEF

published on 06/06/2025 at 20:27, 9 months 17 days ago

Sanofi annonce un rachat d'actions propres début juin 2025

Rachat D'actions Marché XPAR 2025 Sanofi Transaction Sur Actions
PRESS RELEASE

published on 06/06/2025 at 20:22, 9 months 17 days ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 9 months 17 days ago

Sanofi : Déclaration des transactions sur actions propres
Sanofi déclare les transactions sur actions propres du 02 Juin 2025 au 06 Juin 2025 conformément à la réglementation. Présentation agrégée par jour et par marché

Actions Propres Transactions Réglementation Sanofi Présentation Agrégée
BRIEF

published on 06/02/2025 at 07:05, 9 months 22 days ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
BRIEF

published on 06/02/2025 at 07:05, 9 months 22 days ago

Sanofi va acquérir Blueprint Medicines pour 9,5 milliards de dollars

Maladies Rares Acquisition De Sanofi Médicaments Blueprint Pipeline D'immunologie Mastocytose Systémique
PRESS RELEASE

published on 06/02/2025 at 07:00, 9 months 22 days ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 9 months 25 days ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/30/2025 at 07:05, 9 months 25 days ago

L'itepekimab atteint son critère d'évaluation principal dans l'étude de phase 3 sur la BPCO

Sanofi BPCO Regeneron Itepekimab AERIFY-1

Published on 03/24/2026 at 08:01, 11 minutes ago

Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 1 hour 12 minutes ago

Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 1 hour 12 minutes ago

Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 00:55, 7 hours 17 minutes ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 9 hours 32 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements

View all ACCESSWIRE

Published on 03/24/2026 at 08:00, 12 minutes ago

Transaction in Own Shares
Published on 03/24/2026 at 07:30, 42 minutes ago

Drägerwerk AG & Co. KGaA: Dräger with good order development, record net sales and significant increase in net profit in fiscal year 2025 – third dividend increase in a row
Published on 03/24/2026 at 07:23, 48 minutes ago

INDUS confirms a solid financial year 2025 – Proposed dividend of EUR 1.30 exceeds previous year
Published on 03/24/2026 at 07:00, 1 hour 12 minutes ago

After strong fourth quarter, INFICON closes 2025 at record sales level
Published on 03/24/2026 at 07:00, 1 hour 12 minutes ago

Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved

View all EQS

Published on 03/24/2026 at 07:45, 27 minutes ago

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 27 minutes ago

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 42 minutes ago

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
Published on 03/24/2026 at 07:30, 42 minutes ago

Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities
Published on 03/23/2026 at 19:08, 13 hours 4 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026

View all LES ECHOS COMFI WIRE

News